Massachusetts, US, 6th July 2025, ZEX PR WIRE, Dr. Christopher E. Touloukian, a board-certified surgical oncologist and general surgeon, has officially surpassed 2,367 citations on ResearchGate, a leading platform for academic publishing and peer collaboration. This milestone reflects Dr. Touloukian’s enduring contributions to the field of cancer immunotherapy and underscores the global influence of his two-decade-long commitment to improving cancer treatment through rigorous research and surgical innovation. A Career Built on Translational Excellence Dr. Touloukian’s path in medicine began with his graduation from Columbia University College of Physicians and Surgeons,…
Read MoreDay: July 6, 2025
Introducing Tearline’s FlowAgent: A Modular AI Agent Bridging the Execution Trust Gap
British Virgin Islands, BVI, 6th July 2025, ZEX PR WIRE, Enterprise-level adoption of AI agents has reached a critical turning point, yet the majority of implementations fail at the execution layer. While current AI agents excel at understanding intent, they consistently struggle to deliver reliable, auditable actions across fragmented multi-chain ecosystems. FlowAgent, developed by Tearline, represents a fundamental breakthrough in bridging this execution gap through transparent, verifiable automation. It is more than a Web3 automation layer. It’s a transparent, modular, programmable coordination engine — turning high-level intent with natural languages…
Read More